Literature DB >> 15103679

Determining shelf life by comparing degradations at elevated temperatures.

Robert T Magari1, Ileana Munoz-Antoni, Jennifer Baker, Daniel J Flagler.   

Abstract

The degradation of a biological product follows a specific pattern that depends on the kinetics of the chemical reaction. For most biological and pharmaceutical products, accelerated stability tests are preferred to establish shelf life. We describe a new approach for accelerated stability tests, for situations in which the Arrhenius equation is not appropriate. This approach consists of estimating stability at elevated temperatures and comparing these results with the stability estimates for a similar product with a known shelf life. In this article, "Test" refers to Immuno-Trol Low Cells, and "Control" (the product with a known shelf life) refers to Immuno-Trol Cells. The degradation rates and stabilities at elevated temperatures of three antigens of the Test are estimated and compared to their respective Control values. Most of the degradation occurs at the beginning of the experimental period and then slows down until it levels off to form a plateau at the minimum level. Both Control and Test showed similar degradation patterns at three elevated temperatures, indicating that they both have the same mechanism of degradation. Thus, it is expected that they will degrade similarly at storage temperature and have nonsignificantly different shelf lives. The approach for accelerated stability testing discussed here is applicable to situations in which the Arrhenius equation is not appropriate, and the chemical properties of both the Test and Control products are similar. Copyright 2004 Wiley-Liss, Inc.

Mesh:

Substances:

Year:  2004        PMID: 15103679      PMCID: PMC6807887          DOI: 10.1002/jcla.20016

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  4 in total

1.  Estimating degradation in real time and accelerated stability tests with random lot-to-lot variation: a simulation study.

Authors:  Robert T Magari
Journal:  J Pharm Sci       Date:  2002-03       Impact factor: 3.534

2.  Stability parameter estimation at ambient temperature from studies at elevated temperatures.

Authors:  I T Some; P Bogaerts; R Hanus; M Hanocq; J Dubois
Journal:  J Pharm Sci       Date:  2001-11       Impact factor: 3.534

3.  Design and analysis of accelerated degradation tests for the stability of biological standards I. Properties of maximum likelihood estimators.

Authors:  M S Tydeman; T B Kirkwood
Journal:  J Biol Stand       Date:  1984

4.  Statistical prediction of drug stability based on nonlinear parameter estimation.

Authors:  S Y King; M S Kung; H L Fung
Journal:  J Pharm Sci       Date:  1984-05       Impact factor: 3.534

  4 in total
  2 in total

1.  Use of chimeric antibodies as positive controls in an enzyme-linked immunosorbent assay for diagnosis of scrub typhus (infection by Orientia tsutsugamushi).

Authors:  Martina L Jones; Ross T Barnard
Journal:  Clin Vaccine Immunol       Date:  2007-08-08

2.  Benefits of combinations of vitamin A, C and E derivatives in the stability of cosmetic formulations.

Authors:  Mirela Donato Gianeti; Lorena Rigo Gaspar; Flávio Bueno de Camargo; Patrícia Maria Berardo Gonçalves Maia Campos
Journal:  Molecules       Date:  2012-02-22       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.